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Introduction 
The gastrointestinal tract of an animal provides an 
attractive niche for organisms which have evolved to 
withstand its unique challenges. Nutrients ingested by 
the host are in steady supply and obviate the need to 
seek food. In the intestines, the outer mucus layer al-
lows colonization and provides a nutrient rich hab-
itat, while the dense inner layer segregates coloniz-
ing microbes from the dense concentration of immune 
cells in the intestinal epithelium.1 To take advantage 
of these resources, organisms must be equipped to 
tolerate gut conditions: absence of oxygen; physiolog-
ical temperatures (in mammals); peristaltic contrac-
tions and consequent movement of GI contents; vari-
able pH, from the highly acidic stomach to the alkaline 
intestinal mucosa. 
For most years since the development and accep-
tance of the germ theory, studies of human-associated 
microbes focused on pathogens.2 While the existence 
of commensal and mutualistic relationships between 
humans and their gut microbiota has been known for 
well over a century (see, e.g., refs3,4), culture-based 
methods precluded study of any but the most tracta-
ble organisms. The development of culture-indepen-
dent PCR-based methods revolutionized the study of 
the whole, healthy, human microbiome.2 At the turn of 
the century, several large scale international healthy 
human microbiome projects were initiated.5-7 With the 
decrease in cost and rise in capacity of next-genera-
tion sequencing technologies, microbiome projects are 
now more feasible to the single investigator. The con-
tribution of the microbiome to overall well-being is now 
widely accepted and studied. 
The healthy human gut microbiome contains mem-
bers of all domains of life, with Eukarya primarily 
represented by the fungi and, in some populations, 
protists, notably Blastocystis.8,9 The fungal compo-
nent—the mycobiome—has received little attention 
compared with bacteria, but steady work by a num-
ber of researchers has produced a mature discipline, 
as evidenced by this special issue. Several important 
reviews have been published in this decade. Specif-
ically, whole-body perspectives of the human myco-
biome are provided by Cui and colleagues, 10 Huffna-
gle and Noverr,11 Seed,12 and Underhill and Iliev,13 
while the gut mycobiota is reviewed by Ianiro and col-
leagues,14 Kirschner and colleagues,15 and Suhr and 
Hallen-Adams.16 The role of the gut mycobiota in dis-
ease is reviewed by Moyes and Naglik,17 Wang and col-
leagues,18 Gouba and Drancourt,19 Mukherjee and col-
leagues,20 and Richard and colleagues.21 In this paper, 
we focus on the gut mycobiome of healthy humans, 
with a particular emphasis on the relatively few fungi 
that are widely distributed in human gut samples. We 
will also discuss the contributions of diet and the en-
vironment to gut fungal composition, and the stability 
of the gut mycobiome over time. 
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Abstract 
Many species of fungi have been detected in the healthy human gut; however, nearly half of all taxa reported have only been found in one 
sample or one study. Fungi capable of growing in and colonizing the gut are limited to a small number of species, mostly Candida yeasts 
and yeasts in the family Dipodascaceae (Galactomyces, Geotrichum, Saprochaete). Malassezia and the filamentous fungus Cladosporium are 
potential colonizers; more work is needed to clarify their role. Other commonly-detected fungi come from the diet or environment but ei-
ther cannot or do not colonize (Penicillium and Debaryomyces species, which are common on fermented foods but cannot grow at human 
body temperature), while still others have dietary or environmental sources (Saccharomyces cerevisiae, a fermentation agent and sometime 
probiotic; Aspergillus species, ubiquitous molds) yet are likely to impact gut ecology. The gut mycobiome appears less stable than the bac-
terial microbiome, and is likely subject to environmental factors. 
Keywords: Candida, Cladosporium, dietary fungi; Dipodascaceae, gut fungal ecology, gut mycobiome, gut mycobiota, Malassezia, yeasts 
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Many fungi have been reported from the human gut, 
but few are common. From 36 studies spanning 1917 
to 2015 and using a broad array of culture-based and 
nonculture- based methods, 267 distinct, valid spe-
cies were detailed.16 (Taxa identified only to genus, or 
as “undescribed,” in the studies were not included in 
this tally.) Two hundred species, or nearly 75%, were 
only reported in one study. A further 37 species were 
reported in 2 studies, and only 15 were reported in 5 
or more studies. When studies involve multiple sam-
ples a similar trend is observed: many species may be 
observed, but a majority are only detected in a single 
sample. The studies from our own lab identified 97 dis-
tinct fungal taxa in 85 samples from 60 subjects.22,23 
Forty-eight taxa were limited to a single sample, while 
14 occurred in 10 samples or more. The most com-
monly reported genera and species of gut fungi are 
given in Table 1. Most rarely detected taxa are unlikely 
to play a role in gut ecology or host health, for reasons 
discussed below. 
Categories of gut fungi 
Fungi detected in the human gut can be split into res-
ident and non-resident. As a minimum requirement, 
a resident (or autochthonous) fungus must be able to 
grow at 37_C to colonize the gut. For a few species of 
the wide and diverse yeast genus Candida, the mam-
malian digestive tract can be considered the primary 
niche. Species including Candida albicans, C. tropica-
lis, C. parapsilosis, and C. glabrata may all be found 
as natural, asymptomatic components of the human 
microbiome, and published estimates of C. albicans 
carriage in healthy individuals range from 30–60%.24 
Furthermore, many of these species do not appear 
to have a niche apart from living mammals; absent 
a source of contamination, they will not be found in 
significant concentrations in the air, or in soil, or in 
food.25,26 Malassezia is another genus of yeasts whose 
primary niche is the mammalian microbiome; in fact, 
Malassezia species have lost the ability to synthesize 
their own lipids, so they are dependent on a host for 
their nutritional needs.27 The known niche for Malas-
sezia is skin, where it is the predominant fungal ge-
nus detected in 11 of 14 body sites (the exceptions all 
being on the foot; ref.28). Malassezia has also been re-
ported in significant abundance in fecal samples and 
may play a role in the gut.29,30,23 To determine whether 
any Malassezia is indigenous to the gut would require 
more invasive sampling techniques than the standard 
fecal collection, to eliminate the possibility of inocula-
tion of the feces by skin flora. 
Two further groups of fungi reported repeatedly in 
gut fungal studies likely do not have the gut as their 
primary niche but may be considered potential colo-
nizers: Cladosporium, and yeasts in the Dipodasca-
ceae (includes Geotrichum/Saprochaete and Galac-
tomyces). Cladosporium, along with Aspergillus and 
Penicillium (discussed below) is a filamentous fungus, 
or mold; the other fungi commonly detected in the gut 
are all yeasts. Cladosporium has been reported in the 
healthy human GI tract (ileum as well as fecal sam-
ples) since 1969,31 and was widespread in the micro-
biota of Apollo astronauts.32 In the Dipodascaceae, 
yeasts in the genus Galactomyces have been reported 
in 22% of gut fungal studies, with Galactomyces ge-
otrichum reported in 19% (see Table 1). A species re-
lated, but not identical, to Geotrichum gigas in the 
Dipodascaceae was detected in 54% of 69 samples by 
Hallen-Adams and colleagues,22 but has only been re-
ported from this study. Cladosporium and Dipodas-
caceae yeasts most likely enter the gut from environ-
mental sources, but their occurrence is sufficiently 
common that some degree of colonization cannot be 
ruled out. 
Table 1. Most commonly-detected fungi in gut mycobiome 
studies. 
Taxona             # studies  # samples  Referencesd  
 (%)b        (%)c
Candida  32 (86%)  68 (80%) 
  C. albicans  26 (70%)  18 (21%)  3, 9, 22, 23, 31-33, 41-44, 46, 54-
57, 59, 60-63, 65, 66, 68, 69 
  C. tropicalis  17 (46%)  57 (67%)  3, 22, 23, 29, 30- 33, 42, 44, 51, 
54, 55, 60, 61, 62, 68 
  C. parapsilosis  13 (35%)  2 (2%)  9, 22, 30-33, 42, 55, 60, 61, 63, 
67, 68, 69 
  C. glabrata  12 (32%)  0  3, 31, 41, 43, 44, 46, 54, 55, 59, 
60, 61, 63 
  C. krusei  10 (27%)  0  3, 23, 31-33, 44, 45, 54, 55, 60, 63 
  C. lusitaniae  6 (16%)  0  30, 33, 43, 54, 55, 60 
Saccharomyces  20 (54%)  5 (6%) 
  S. cerevisiae  20 (54%)  5 (6%)  9, 22, 23, 30, 33, 34, 41-45, 51, 
54, 58, 59, 61-64, 69 
Penicillium  14 (38%)  17 (20%)  9, 22, 42, 69d 
  P. aff. commune  10 (27%)  10 (12%)  23, 29, 31, 41, 43, 44, 51, 58, 62, 
67 
Aspergillus  12 (32%)  20 (24%)  22, 23, 42, 43, 51, 58, 62 
  A. aff. versicolor  5 (14%)  0  9, 29, 31, 44, 67 
Cryptococcus  10 (27%)  3 (4%)  3, 22, 23, 30, 31, 41, 42, 60-62 
Malassezia  11 (30%)  21 (25%)  69 
  M. globosa  8 (22%)  1 (1%)  23, 29, 30, 34, 42, 43, 45, 58 
  M. restricta  7 (19%)  20 (24%)  22, 23, 29, 30, 43, 45, 58 
  M. pachydermatis  6 (16%)  1 (1%)  23, 29, 43, 44, 45, 58 
Cladosporium  10 (27%)  15 (18%) 
  C. aff. herbarum  10 (27%)  18 (21%)  22, 23, 30, 31, 32, 41, 43, 58, 61, 
67 
Galactomyces  8 (22%)  8 (9%)  60 
  G. geotrichum  7 (19%)  7 (8%)  9, 22, 29, 41, 43, 44, 45 
Debaryomyces  8 (22%)  18 (21%) 
  D. hansenii  7 (19%)  18 (21%)  22, 23, 30, 34, 43, 54, 59 
Trichosporon  6 (17%)  8 (9%)  22, 30, 33, 41, 43, 45 
a. Bold type refers to the genus as a whole; italics indicates individual species. 
b. Based on 37 papers giving species-level identifications,  published between 
1917–2016. 
c. Based on 85 samples published in refs. 22 & 23. 
d. References for genus are only given if they are distinct from species references 
for that genus.  
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Saccharomyces cerevisiae – bakers’ and brewers’ 
yeast – in the gut presumably originates in food.33,34 
We would not consider S. cerevisiae an autochthonous 
gut organism nor a true human commensal (although 
it is often called commensal in the literature); it is a 
domesticated species of fermentations whose “wild” 
niche is associated with plants. However, the ability 
of strains to grow at 37°C and the opportunities for 
repeated introduction render it among the most com-
monly detected fungi in fecal samples, and it likely con-
tributes to gut microbial ecology. Probiotic S. cerevisiae 
(“S. boulardii”) does not persist for more than 5 d af-
ter administration stops in healthy subjects,35 but has 
given rise to an increasing incidence of Saccharomyces 
fungemia when co-morbidities are present.36 Many As-
pergillus species fall into a similar category – they sur-
vive human physiological temperatures, but are much 
more commonly reported in environmental (soil, air, 
plant matter) than in gut samples, and are presumably 
of environmental origin.37,38 Like S. cerevisiae, the po-
tential for these species to persist and respond to the 
gut environment (see below) means they may play a 
role in the gut, regardless of preferred niche. 
Other commonly-detected fungi include Debaryomy-
ces hansenii and Penicillium aff. commune, foodborne 
species incapable of growing at 37 °C.39,40 Finally, there 
is the long tail of rarely-detected fungi which make up 
most of the species richness in gut mycobiota studies 
but whose presence in human fecal samples is strictly 
incidental and cannot be assumed to influence the 
gut ecology. These include edible mushrooms,23 plant 
pathogens (widely reported; see, e.g. refs.41-43), xero-
philes (Wallemia sebi and W. muriae),44 wood decay 
fungi,22,45,46 and other organisms whose growth and 
nutrition requirements preclude any lasting role in the 
mammalian GI tract. 
Influence of diet on gut fungi 
The gut microbiome has been presumed sterile until 
birth, although detection of bacteria in amniotic fluid 
and in the meconium have raised recent challenges to 
that assumption.47 Starting at birth and throughout life, 
the primary route for microbes to enter the gastrointes-
tinal tract is via ingestion,48 although inhalation can 
play a role as well. The first fungi detected in the infant 
gut are Saccharomycetalean yeasts, especially Candida 
species; these are presumed to be transmitted by the 
mother as Candida species are common inhabitants of 
the skin and vaginal mucosa as well as the colon.49 
Providing both a means of entrance for microorgan-
isms to the gut, and a major source of nutrients for es-
tablished microbes, the diet is an obvious influence on 
gut microbial composition. David and colleagues found 
broad, reproducible, dietary-induced changes in the 
gut microbiome depending on whether volunteers con-
sumed a plant- or an animal-based diet.34 While bac-
terial composition showed a clear response to nutri-
ent availability (carbohydrates/fiber vs. proteins and 
fats), fungal composition appeared to be driven by food 
colonization. Notably, the same species of fungi were 
detected in participant fecal samples and in cheese 
fed to those participants. 34 Hoffmann and colleagues 
found that Candida abundance was positively corre-
lated with recent consumption of carbohydrates and 
negatively correlated with total saturated fatty acids.50 
Recent consumption of short chain fatty acids drove 
down the abundance of Aspergillus.50 Ukhanova et al. 
found a decrease in Candida and Penicillium related to 
almond and pistachio consumption.51 
Finally, Suhr and colleagues examined 16 samples 
from 15 vegetarians, while Hallen-Adams et al. used 
the same methodology in the same laboratory to iso-
late and sequence fungal DNA from 69 samples from 
45 people on a conventional Western diet.22,23 The dis-
tribution of fungi differed considerably between the 2 
groups (Table 2). Plant pathogenic Fusarium was de-
tected in all but 2 samples from vegetarians (14 sam-
ples; 88%), while it was only detected in 2 samples 
from participants on conventional diets (3%). Malasse-
zia and (presumed) foodborne Penicillium and Aspergil-
lus were also present in more than 50% of vegetarian 
samples but much rarer in conventional diet samples. 
Common fungi were also proportionally more common 
in vegetarian samples; the top 5 genera were detected 
in 88, 81, 75, 68 and 63% of samples, respectively, 
while the top 5 genera in conventional diet samples 
were detected in 84, 46, 16, 16 and 12%. These differ-
ences are not due solely to the smaller sample set for 
vegetarians; Fusarium, Malassezia, Penicillium and As-
pergillus were detected in a higher number of vegetar-
ian than conventional diet samples. Conversely, David 
and colleagues found a significant enrichment of Peni-
cillium in participants on an animal-based diet than on 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Most common taxa in vegetarian and conventional diet 
samples. 
Genus  Vegetarian  Conventional 
Fusarium  14 (88%)  2   (3%) 
Candida  10 (63%)  58 (84%) 
Malassezia  13 (81%)  8 (12%) 
Penicillium  12 (75%)  1   (1%) 
Aspergillus  11 (68%)  4   (6%) 
Geotrichum  ND  32 (46%) 
Pichia  1   (6%)  11 (16%) 
Cladosporium  4   (25%)  11 (16%) 
Data from refs. 22 & 23.  
4 Hallen-Adams & Suhr in Virulence (2016) 
a plant-based diet (and an overall enrichment in fun-
gal transcripts and CFUs on the animal-based diet);34 
however, their controlled animal-based diet was rich in 
cheeses, including Camembert and blue which are pro-
cessed with Penicillium and were absent from the plant-
based diet. The vegetarian subjects in Suhr et al.22 in-
cluded lacto-ovo vegetarians, who consume dairy. 
Studies to date provide intriguing hints about the 
role of diet in influencing the gut mycobiome, but 
broad conclusions are precluded by the limited num-
ber of studies and the differing methodologies. To 
date, only David et al. have conducted a controlled 
diet study;34 their findings were sufficiently dramatic 
to demonstrate the benefit of such studies. Additional 
studies, involving multiple locations and populations 
and incorporating detailed dietary information, would 
be valuable in clarifying the impact of diet on fungi. 
Environmental sampling for studies taking place in cir-
cumscribed environments, such as hospitals, and sam-
pling of participants’ skin and oral mycobiome, could 
suggest other sources of gut fungi. 
Stability of the gut mycobiome 
While the stability of the bacterial microbiome is now 
well-documented (e.g., ref.52), the situation in fungi is 
less clear. Comparatively few studies have genus- or 
species- level fungal data for multiple samples from the 
same subject over time, and those who have addressed 
the issue have reached differing conclusions. Our own 
impression, based on samples at 2 time points each 
from 24 participants, is that the composition of the 
gut mycobiome is not particularly stable; we found the 
same fungus at both time points less than 20% of the 
time.22 Given the high proportion of rare, incidental 
taxa detected in fecal samples, we eliminated these 
taxa from consideration, which led to a slight increase; 
commonly-detected gut fungi were detected in both 
time points 27% of the time. In this dataset only the 
most common fungus, Candida tropicalis, was present 
at both time points a majority of the time (58%). 
Mouse studies have shown variability over time,53 
leading Underhill and Iliev to generalize that “(t)his 
suggests that commensal fungal populations are more 
variable than those of bacteria and that they may be 
influenced by fungi in the environment.”13 Anderson, 
writing near the advent of gut mycobiota studies ob-
served “(t)he blastomycetes [= yeasts] must, for the 
present be regarded as accidental ingredients of the 
feces, since in the same case observed at different pe-
riods they vary so extraordinarily”3 Possibly in contra-
diction of the foregoing, Cohen and colleagues report 
“(t)he stability of the mycofloral pattern of the small 
intestine was demonstrated in 5 subjects who were 
resampled 5 to 9 months after the initial studies; the 
fungal pattern was qualitatively and quantitatively un-
changed,”31 however, these authors sampled from mul-
tiple parts of the GI tract and specified the small in-
testine in their observations, while other studies have 
been limited to the feces. More studies, with samples 
collected over multiple time points, are needed to ad-
dress the matter of gut mycobiome persistence. 
Concluding remarks 
Multiple studies have now provided a baseline snap-
shot of the gut mycobiome in healthy individuals. 
While more studies and more samples would address 
some outstanding questions (are there geographical 
differences in mycobiome? Differences based on age, 
gender or other demographic factors?), we can begin to 
make some broad generalizations about which groups 
of fungi are likely to be of importance to the host and 
the overall microbiome. As far as possible, new stud-
ies should take diet and the environment into ac-
count, which can be as simple a matter as requesting 
a dietary log and including one or more relevant skin 
(hands and face may come into contact with food and 
contribute organisms which are then swallowed, while 
elbow or foot samples are not likely to) and oral sam-
ple from participants. Sequencing multiple samples 
over time from as large a pool of participants as possi-
ble would be highly desirable; at present, mycobiome 
studies lag far behind bacterial microbiome studies in 
terms of numbers and consequent statistical power. 
Many unanswered questions remain about those 
fungi whose niche is the gut: what are they doing in 
a healthy host, and would their absence be detrimen-
tal? Are species interchangeable, i.e., is there any ef-
fect in replacing Candida albicans with C. tropicalis 
or C. parapsilosis in an individual host? Do species, 
or strains of the same species, compete and, if so, are 
there predictable outcomes? – Given the importance of 
Candida yeasts as opportunistic pathogens, answer-
ing these questions could provide insight into limiting 
or preventing yeast infections or candidiasis. Whether 
there are gut-resident strains or species of Malasse-
zia or Cladosporium remains to be answered as well.  
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